FDA Clears Allogene's IND for CAR T Therapy in Autoimmune Diseases

Published on 29 Jan 2025 on Zacks · via Yahoo Finance

The FDA clears ALLO's investigational new drug application to start clinical studies on its...

Read the rest of the article

Start tracking your investments with Statfolio

The FDA clears ALLO's investigational new drug application to start clinical studies on its...

Zacks · via Yahoo Finance 29 Jan 2025

Allogene Therapeutics Inc (ALLO) reports a strong cash position and promising clinical progress,...

GuruFocus.com · via Yahoo Finance 8 Nov 2024

Allogene Therapeutics Inc (NASDAQ:ALLO) is set to release its Q3 2024 earnings on Nov 7, 2024. Th...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

We recently compiled a list of the 7 Best Rising Penny Stocks To Invest In Now. In this article, ...

Insider Monkey · via Yahoo Finance 6 Oct 2024

We recently compiled a list of the 10 Worst Cancer Stocks To Buy Now According to Short Sellers. ...

Insider Monkey · via Yahoo Finance 19 Sep 2024

Key Insights Significantly high institutional ownership implies Allogene Therapeutics' stock pric...

Simply Wall St. · via Yahoo Finance 18 Jun 2024

We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 18 Jun 2024

Allogene Therapeutics (ALLO) delivered earnings and revenue surprises of 0% and 47.62%,...

Zacks · via Yahoo Finance 24 Apr 2024

One stock that might be an intriguing choice for investors right now is Allogene Therapeutics, In...

Zacks via Yahoo Finance 8 Apr 2024

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript March 14, 2024 Allogen...

Insider Monkey via Yahoo Finance 16 Mar 2024